Australija -
engleski -
Department of Health (Therapeutic Goods Administration)
zolacos cp combination goserelin 10.8mg (as acetate) implant syringe and bicalutamide 50mg tablet blister pack
astrazeneca pty ltd - goserelin, quantity: 10.8 mg - implant - excipient ingredients: polyglactin - for the treatment of advanced prostate cancer. bicalutamide is also indicated for the prevention of disease flare associated with initial goserelin treatment
Australija -
engleski -
Department of Health (Therapeutic Goods Administration)
zolacos cp combination goserelin 3.6mg (as acetate) implant syringe and bicalutamide 50mg tablet blister pack
astrazeneca pty ltd - goserelin, quantity: 3.6 mg - implant - excipient ingredients: polyglactin - for the treatment of advanced prostate cancer. bicalutamide is also indicated for the prevention of disease flare associated with initial goserelin treatment.
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
reseligo (goserelin alvogen) vefjalyf í áfylltri sprautu 3,6 mg
alvogen ehf. - goserelinum acetat - vefjalyf í áfylltri sprautu - 3,6 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
reseligo (goserelin alvogen) vefjalyf í áfylltri sprautu 10,8 mg
zentiva k.s.* - goserelinum acetat - vefjalyf í áfylltri sprautu - 10,8 mg
Poljska -
poljski -
URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)
xanderla la 10,8 mg implant w ampułko-strzykawce
teva pharmaceuticals polska sp. z o.o. - goserelini acetas - implant w ampułko-strzykawce - 10,8 mg
Slovenija -
slovenski -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
reseligo 3,6 mg implantat v napolnjeni injekcijski brizgi
alvogen ipco s.ar.l - goserelin - implantat - goserelin 3,6 mg / 1 brizga - goserelin
Slovenija -
slovenski -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
reseligo 10,8 mg implantat v napolnjeni injekcijski brizgi
alvogen ipco s.ar.l - goserelin - implantat - goserelin 10,8 mg / 1 brizga - goserelin
Slovenija -
slovenski -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
zoladex 3,6 mg implantat v napolnjeni injekcijski brizgi
astrazeneca ab - goserelin - implantat - goserelin 3,6 mg / 1 brizga - goserelin
Slovenija -
slovenski -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
zoladex 10,8 mg implantat v napolnjeni injekcijski brizgi
astrazeneca ab - goserelin - implantat - goserelin 10,8 mg / 1 brizga - goserelin
Poljska -
poljski -
URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)
xanderla 3,6 mg implant w ampułko-strzykawce
teva pharmaceuticals polska sp. z o.o. - goserelini acetas - implant w ampułko-strzykawce - 3,6 mg